Table 2.

Evaluation of the diagnosis segmentation model using automatic extraction

Textual elements	First round with the validation set (n = 496)						Second round with the validation set (n = 488)						Test set (n = 532)
	TP	FP	FN	P (%)	R (%)	F1 (%)	TP	FP	FN	P (%)	R (%)	F1 (%)	TP	FP	FN	P (%)	R (%)	F1 (%)
Tumor recurrence	134	0	0	100.0	100.0	100.0	134	0	0	100.0	100.0	100.0	98	0	0	100.0	100.0	100.0
Tumor location	477	0	4	100.0	99.2	99.6	476	0	0	100.0	100.0	100.0	531	0	1	100.0	100.0	100.0
Invasiveness	166	0	1	100.0	99.4	99.7	165	0	0	100.0	100.0	100.0	128	0	0	100.0	100.0	100.0
Endocrine status	410	0	32	100.0	92.8	96.3	437	0	0	100.0	100.0	100.0	464	1	5	99.8	98.9	99.3
Tumor size	341	0	0	100.0	100.0	100.0	338	0	0	100.0	100.0	100.0	394	0	0	100.0	100.0	100.0
Histopathology	477	0	19	100.0	96.2	98.1	488	0	0	100.0	100.0	100.0	529	0	3	100.0	99.4	99.7
Knosp grading	44	0	3	100.0	93.6	96.7	46	0	0	100.0	100.0	100.0	2	0	0	100.0	100.0	100.0
Residual tumor	4	0	0	100.0	100.0	100.0	4	0	0	100.0	100.0	100.0	8	0	0	100.0	100.0	100.0
Diagnostic confirmation	76	0	3	100.0	96.2	98.1	78	0	0	100.0	100.0	100.0	18	0	1	100.0	94.7	97.3
Refractoriness*	2	0	0	100.0	100.0	100.0	2	0	0	100.0	100.0	100.0	-	-	-	-	-	-

*No PA diagnostic statement contained textual element of refractoriness in the test set